Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC11A2 | P49281 | 1/20 | 0.37 |
| ▸ | PGK1 | P00558 | 1/20 | 0.33 |
| ▸ | PGK2 | P07205 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2813984 | 1.00 | SLC11A2 (0.37) | SLC11A2PGK1PGK2MEN1KMT2A | |
| SCHEMBL2816363 | 0.79 | PGK1 (0.32) | PGK1PGK2 | |
| SCHEMBL2816365 | 0.79 | PGK1 (0.32) | PGK1PGK2 | |
| SCHEMBL13130266 | 0.79 | PGK1 (0.32) | PGK1PGK2 | |
| SCHEMBL2814521 | 0.78 | SMN1; SMN2 (0.32) | SLC11A2PGK1PGK2ALDH1A1 | |
| SCHEMBL13994531 | 0.72 | SLC11A2 (0.33) | SLC11A2 | |
| SCHEMBL2807981 | 0.72 | SLC11A2 (0.52) | SLC11A2PGK1PGK2 | |
| SCHEMBL13130253 | 0.70 | — | — | |
| SCHEMBL2816366 | 0.70 | SLC11A2 (0.36) | SLC11A2PGK1PGK2MEN1KMT2A | |
| SCHEMBL10455929 | 0.68 | GRIN2D (0.59) | MEN1KMT2AALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100240713-A1 | AROMATIC AND HETEROAROMATIC COMPOUNDS USEFUL IN TREATING IRON DISORDERS | XENON PHARMACEUTICALS INC. (CA) | 2010-09-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100240713-A1 | AROMATIC AND HETEROAROMATIC COMPOUNDS USEFUL IN TREATING IRON DISORDERS | SLC40A1, PAH, FECH | SLC11A2 175/4885PGK1 1732/4885PGK2 1971/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.